1[1]Nagele T,Ptersen D,Klose U,et al.Dynamic contrast enhancement of intracranial tunors with snapshotFLASH MR imaging.AJNR, 1993,14:89-98.
2[2]Muller TB,Haraldseth O,Jones RA,et al. Combined perfusion and diffusion-weighted magnetic resonance imaging in a rat model of reversible middle cerebral artery occlusion. Stroke,1995,26:451-457.
3[3]Hou L,Yang Y,Mattay VS,et al.Optimization of fast acqusition methods for whole-brain relative cerebral blood volume mapping with susceptibility contrast agents. Magn Reson Imaging, 1999,9(1):233-239.
4[4]Simonsen CZ,Ostergaard L,Vestergaard-Poulsen P,et aI.CBF and CBV measurementsby USPIO bolus tracking: reproducibility and comparison with Gd-based values.J Magn Reson Imaging,1999,9(2):342-347.
5[5]Jezzard P.Advanced in perfusion MR imaging. Radiology, 1998,208(1):296-299.
7[7]Frank JA,Ostuni JL,Yang Y,et al. Technical solution for an interactive functional MR imaging examination:application to a physiologic interview and the study of cerebral physiology.Radiology, 1999,210(1): 260-268.
8[8]Petrella JR,Provenzale JM.MR Perfusion imaging of the brain:techniques and applications. A JR,2000, 175(1):207-219.
9[9]Cha S, Lu S,Johnson G,et al.Dynamic susceptibility contrast MR imaging correlation of signal intensity changes with cerebral blood volume measurement. J Magn Imaging, 2000, 11: 114
10[10]Kupprsamy K, Lin W, Cizek G,et al. In vivo regional cerebral blood volume: Quantitative assessment with 3D T1-weighted pre-and postcontrast MR imaging. Radiology, 1996,201(1): 106-112.
4[2]Heard BE. Benign sclerosing haemangioma of the lung[J].Histopathology, 1986,10(5):541～ 542.
5[3]Xu HM, Li WH, Hou N, et al. Neuroendocvine differentiation 32lases of so-called sclerosing hemangioma of the hung:dentified by immunohistochemical and ultrastructural study [J].Am J Surg Pathol, 1997,21(9):1013～ 1022.
6[5]Chan AC,Chan JK. Pulmonary scherosing hemangioma consistently expresses thyroid transcription factor-1(TTF1):a new clue to its histogensis[J].Am J Surg Pathol,2000,24(11):1531～ 1536.
